Antimicrobial stewardship in low- and middle-income countries: Access versus adherence

Source briefing · A concise briefing based on one linked source. It is intentionally shorter than a full FreedomWitness Evidence Engine analysis.

What the source reports

by Kiarah Shchepanik, Anthony D. Bai, Heather Wise Can improving access to antimicrobial guidelines improve prescriber adherence?

In a recent study published in PLOS Medicine (the LAMPA trial), a smartphone app did not improve adherence despite enhanced access to guidelines, highlighting that prescriber behavior is complex, and effective antimicrobial stewardship interventions need to be multifaceted and sustained. This Perspective by Kiarah Shchepanik and colleagues discusses results from the recent LAMPA trial, in which a smartphone app did not improve adherence to antimicrobial…

Evidence note: At this stage FreedomWitness is presenting what this source reports. This briefing does not independently prove every underlying claim and should be read together with the original material.

Source & verification

Primary source: PLOS Medicine · August 28, 2026

Read the original source

FreedomWitness links to the original source so readers can inspect the underlying material and judge the context for themselves.